Cardiac channelopathies: The role of sodium channel mutations.

Abstract Introduction and objectives The importance of sodium channels for the normal electrical activity of the heart is emphasized by the fact that mutations (inherited or de novo) in genes that encode for these channels or their associated proteins cause arrhythmogenic syndromes such as the Brugada syndrome and the long QT syndrome (LQTS). The aim of this study is to conduct a review of the literature on the mutations in the sodium channel complex responsible for heart disease and the implications of a close relationship between genetics and the clinical aspects of the main cardiac channelopathies, namely at the level of diagnosis, risk stratification, prognosis, screening of family members and treatment. Methods The online Pubmed® database was used to search for articles published in this field in indexed journals. The MeSH database was used to define the following query: “Mutation [Mesh] AND Sodium Channels [Mesh] AND Heart Diseases [Mesh]”, and articles published in the last 15 years, written in English or Portuguese and referring to research in human beings were included. Conclusions In the past few years, significant advances have been made to clarify the genetic and molecular basis of these syndromes. A greater understanding of the underlying pathophysiological mechanisms showed the importance of the relationship between genotype and phenotype and led to progress in the clinical approach to these patients. However, it is still necessary to improve diagnostic capacity, optimize risk stratification, and develop new specific treatments according to the genotype-phenotype binomial.

• Publication year

  2018

• Venue

  Revista Portuguesa De Pneumologia

• Publication date

  2018-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.REPCE.2017.11.016
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiac Channelopathies and Sudden Death: Recent Clinical and Genetic Advances

  2017cited by this paper
• The role of mutations in the SCN5A gene in cardiomyopathies.

  2016cited by this paper
• Management of survivors of cardiac arrest — the importance of genetic investigation

  2016cited by this paper
• The evolution of sports participation guidelines and the influence of genotype-phenotype correlation in long QT syndrome.

  2016influential reference
• Recent advances in genetic testing and counseling for inherited arrhythmias

  2016influential reference
• Impact of clinical and genetic findings on the management of young patients with Brugada syndrome.

  2016cited by this paper
• Pathogenesis and management of Brugada syndrome

  2016cited by this paper
• Brugada syndrome: More than 20 years of scientific excitement.

  2016influential reference
• Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery

  2016cited by this paper
• Genetics of Brugada syndrome

  2016cited by this paper
• Ion channel macromolecular complexes in cardiomyocytes: roles in sudden cardiac death.

  2015cited by this paper
• Late Sodium Current in Human Atrial Cardiomyocytes from Patients in Sinus Rhythm and Atrial Fibrillation

  2015cited by this paper
• The cardiac sodium channel gene SCN5A and its gene product NaV1.5: Role in physiology and pathophysiology.

  2015influential reference
• Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement From the American Heart Association and American College of Cardiology.

  2015cited by this paper
• Enhanced Classification of Brugada Syndrome–Associated and Long-QT Syndrome–Associated Genetic Variants in the SCN5A-Encoded Nav1.5 Cardiac Sodium Channel

  2015cited by this paper
• Contribution of Cardiac Sodium Channel β-Subunit Variants to Brugada Syndrome.

  2015cited by this paper
• Asymptomatic Brugada Syndrome: Clinical Characterization and Long-Term Prognosis

  2015cited by this paper
• The Diagnosis, Risk Stratification, and Treatment of Brugada Syndrome.

  2015influential reference
• Brugada syndrome: clinical and genetic findings

  2015cited by this paper
• Inherited ion channel diseases: a brief review.

  2015cited by this paper
• Genetics of long-QT syndrome

  2015cited by this paper
• Genetic and clinical advances in congenital long QT syndrome.

  2014cited by this paper
• Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome.

  2014influential reference
• SCN1B gene variants in Brugada Syndrome: a study of 145 SCN5A-negative patients

  2014influential reference
• Missense Mutations in Plakophilin-2 Cause Sodium Current Deficit and Associate With a Brugada Syndrome Phenotype

  2014influential reference
• Desmosomes and the sodium channel complex: implications for arrhythmogenic cardiomyopathy and Brugada syndrome.

  2014influential reference
• Novel Calmodulin Mutations Associated With Congenital Arrhythmia Susceptibility

  2014cited by this paper
• Genetics of long QT syndrome.

  2014cited by this paper
• Cardiac sodium channel mutations: why so many phenotypes?

  2014influential reference
• Cardiac sodium channelopathy associated with SCN5A mutations: electrophysiological, molecular and genetic aspects

  2013influential reference
• Characterization and Mechanisms of Action of Novel NaV1.5 Channel Mutations Associated With Brugada Syndrome

  2013cited by this paper
• Channelopathies from mutations in the cardiac sodium channel protein complex.

  2013influential reference
• HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013.

  2013influential reference
• A study of the SCN5A gene in a cohort of 76 patients with Brugada syndrome

  2013cited by this paper
• Impact of genetics on the clinical management of channelopathies.

  2013influential reference
• Genotype- and phenotype-guided management of congenital long QT syndrome.

  2013cited by this paper
• Genetics of ion-channel disorders

  2012cited by this paper
• Biology of cardiac sodium channel Nav1.5 expression.

  2012influential reference
• PERTURBATION OF SODIUM CHANNEL STRUCTURE BY AN INHERITED LONG QT SYNDROME MUTATION

  2012influential reference
• Brugada syndrome 2012.

  2012cited by this paper
• Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing.

  2012cited by this paper
• A Clinical Approach to Inherited Arrhythmias

  2012influential reference
• HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

  2011influential reference
• Phenotypical Manifestations of Mutations in the Genes Encoding Subunits of the Cardiac Sodium Channel

  2011influential reference
• Genetic Testing for Potentially Lethal, Highly Treatable Inherited Cardiomyopathies/Channelopathies in Clinical Practice

  2011cited by this paper
• Mutations in sodium channel β-subunit SCN3B are associated with early-onset lone atrial fibrillation.

  2011influential reference
• Advances in Arrhythmia and Electrophysiology Commentary on the Brugada ECG Pattern A Marker of Channelopathy, Structural Heart Disease, or Neither? Toward a Unifying Mechanism of the Brugada Syndrome

  2010cited by this paper
• An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing.

  2010influential reference
• Cardiac sodium channel Na(v)1.5 and interacting proteins: Physiology and pathophysiology.

  2010influential reference
• Sodium channel (dys)function and cardiac arrhythmias.

  2010influential reference
• Genetics and cardiac channelopathies

  2010influential reference
• Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome: Results From the FINGER Brugada Syndrome Registry

  2010cited by this paper
• Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies.

  2009influential reference
• Sodium channel mutations and arrhythmias

  2009influential reference
• Cardiac sodium channelopathies

  2009influential reference
• Prevalence of the Congenital Long-QT Syndrome

  2009cited by this paper
• Subtype‐selective targeting of voltage‐gated sodium channels

  2009cited by this paper
• Cardiac Na+ Current Regulation by Pyridine Nucleotides

  2009cited by this paper
• Mutations in Sodium Channel β1- and β2-Subunits Associated With Atrial Fibrillation

  2009cited by this paper
• SCN5A Mutations and the Role of Genetic Background in the Pathophysiology of Brugada Syndrome

  2009cited by this paper
• SCN4B-Encoded Sodium Channel &bgr;4 Subunit in Congenital Long-QT Syndrome

  2007cited by this paper
• Postmortem long QT syndrome genetic testing for sudden unexplained death in the young.

  2007cited by this paper
• QT Interval: How to Measure It and What Is “Normal”

  2006cited by this paper
• Mutant Caveolin-3 Induces Persistent Late Sodium Current and Is Associated With Long-QT Syndrome

  2006influential reference
• The congenital long QT syndromes from genotype to phenotype: clinical implications

  2006influential reference
• Inherited disorders of voltage-gated sodium channels.

  2005cited by this paper
• Brugada syndrome: report of the second consensus conference.

  2005influential reference
• Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more?

  2005cited by this paper
• Risk stratification in the long-QT syndrome.

  2003cited by this paper
• Risk stratification in the long-QT syndrome.

  2003cited by this paper
• Determinants of Sudden Cardiac Death in Individuals With the Electrocardiographic Pattern of Brugada Syndrome and No Previous Cardiac Arrest

  2003cited by this paper
• Determinants of Sudden Cardiac Death in Individuals With the Electrocardiographic Pattern of Brugada Syndrome and No Previous Cardiac Arrest

  2003cited by this paper
• The Brugada syndrome.

  2002cited by this paper
• [Brugada's syndrome].

  2002cited by this paper
• The long-QT syndrome.

  2000influential reference
• Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts.

  2000cited by this paper
• Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease.

  1998influential reference
• Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias

  1996cited by this paper
• A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome.

  1995cited by this paper
• SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome.

  1995cited by this paper
• Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report.

  1992influential reference
• Life-threatening Arrhythmias Genotype-phenotype Correlation in the Long-qt Syndrome : Gene-specific Triggers for Genotype-phenotype Correlation in the Long-qt Syndrome Gene-specific Triggers for Life-threatening Arrhythmias

  year unknowninfluential reference

• TRATAMENTO CIRÚRGICO DE CARDIOPATIAS CONGÊNITAS EM NEONATOS: AVALIAÇÃO DE RESULTADOS EM PACIENTES COM SÍNDROME DE DOWN

  2024cites this paper
• Identifying genomic variant associated with long QT syndrome type 2 in an ecuadorian mestizo individual: a case report

  2024cites this paper
• Brugada Syndrome: More than a Monogenic Channelopathy

  2023cites this paper
• Ion Channels and Transporters as Therapeutic Agents: From Biomolecules to Supramolecular Medicinal Chemistry

  2022cites this paper
• Protein 14-3-3 Influences the Response of the Cardiac Sodium Channel Nav1.5 to Antiarrhythmic Drugs

  2022cites this paper
• Gene variant effects across sodium channelopathies predict function and guide precision therapy

  2022cites this paper
• TBX5‐encoded T‐box transcription factor 5 variant T223M is associated with long QT syndrome and pediatric sudden cardiac death

  2020cites this paper
• Characterization of Cardiac Electrophysiology Including ECG-Analysis

  2019cites this paper
• Programmed Ventricular Stimulation in the Management of Brugada Syndrome Patients

  2019cites this paper
• Different Cardiotoxicity of Palbociclib and Ribociclib in Breast Cancer: Gene Expression and Pharmacological Data Analyses, Biological Basis, and Therapeutic Implications

  2019influential citation
• The Brazilian Society of Cardiology and Brazilian Society of Exercise and Sports Medicine Updated Guidelines for Sports and Exercise Cardiology - 2019

  2019cites this paper